Health-related Quality of Life in Survivors of Autologous Haematopoietic Stem Cell Transplantation: A Cross-Sectional SF-36 Study from a Tertiary Cancer Centre in India
British Journal of Healthcare and Medical Research · 03.11.2026 · 13 (05) · 397-408
DOI: 10.14738/bjhr.1305.12483 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift British Journal of Healthcare and Medical Research, online erschienen am 03.11.2026. Verfasst von Deepa Aggarwal und 12 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Data on health-related quality of life (HRQoL) of survivors of autologous haematopoietic stem cell transplantation (HSCT) in India are limited. This study describes the HRQoL of autologous HSCT survivors at a tertiary cancer centre in India using the SF-36.
Methods
In this single-centre cross-sectional observational study, survivors of autologous HSCT for multiple myeloma (MM) or lymphoma completed the SF-36 through a self-administered Google Form. Scales were scored by the RAND method and converted to norm-based T-scores; physical (PCS) and mental (MCS) component summaries were derived and compared with general-population norms. Associations with routine demographic, clinical and transplant variables from the institutional database were explored with Spearman correlation (Benjamini–Hochberg correction) and multivariable linear regression.
Results
Forty-six unique survivors responded (21 MM, 25 lymphoma; 57.5% of 80 eligible); median age was 39 years and median time from transplant 21.8 months. Mean PCS was 50.8 ± 6.1 and MCS 52.4 ± 6.5; only 3 (6.5%) and 1 (2.2%) respondents scored below 40, respectively. Vitality exceeded the population norm (T 59.2; 95% CI 57.8–60.7), whereas social functioning was the only domain below it (T 46.9; 95% CI 45.0–48.8). All respondents rated their health as better than one year earlier. Ceiling effects were marked for role-physical (69.6%) and role-emotional (73.9%). HRQoL did not differ between MM and lymphoma (PCS 49.3 vs 52.1; p = 0.378). None of 12 routine demographic and transplant variables — including age, CD34+ dose, engraftment, mucositis and hospital stay — was associated with PCS or MCS after correction for multiple testing, and multivariable models explained 6% (PCS) and 15% (MCS) of variance.
Conclusions
Autologous HSCT survivors attending follow-up reported HRQoL comparable to or above general-population norms, with social functioning the consistent shortfall. Routine transplant variables were not associated with later HRQoL. Ceiling effects, low reliability of two-item scales and survivor selection support prospective, longitudinal measurement with India-specific norms.
Zitieren
APA
Aggarwal, D., Hafeez, M., Benakatti, K., Chakrabarti, S., Ramachandran, S., Reddy, B. R. S. G., Dadmi, P., Shashikiran, M., Koshy, B. E., Koshy, B. E., Rudresh, A. H., Rajeev, L. K., & Lokesh, K. N. (2026). Health-related Quality of Life in Survivors of Autologous Haematopoietic Stem Cell Transplantation: A Cross-Sectional SF-36 Study from a Tertiary Cancer Centre in India. British Journal of Healthcare and Medical Research, 13(05), 397-408. https://doi.org/10.14738/bjhr.1305.12483
Vancouver
Aggarwal D, Hafeez M, Benakatti K, Chakrabarti S, Ramachandran S, Reddy BRSG, et al. Health-related Quality of Life in Survivors of Autologous Haematopoietic Stem Cell Transplantation: A Cross-Sectional SF-36 Study from a Tertiary Cancer Centre in India. British Journal of Healthcare and Medical Research. 2026;13(05):397-408. doi:10.14738/bjhr.1305.12483
BibTeX
@article{Aggarwal2026,
author = {Aggarwal, Deepa and Hafeez, Mohammed and Benakatti, Kashinath and Chakrabarti, Sutanuka and Ramachandran, Sindhuja and Reddy, B R Sai Ganesh and Dadmi, Pooja and Shashikiran, Muddhapuram and Koshy, Beulah Elizabeth and Koshy, Beulah Elizabeth and Rudresh, A. H. and Rajeev, L. K. and Lokesh, K. N.},
title = {Health-related Quality of Life in Survivors of Autologous Haematopoietic Stem Cell Transplantation: A Cross-Sectional SF-36 Study from a Tertiary Cancer Centre in India},
journal = {British Journal of Healthcare and Medical Research},
year = {2026},
volume = {13},
number = {05},
pages = {397--408},
doi = {10.14738/bjhr.1305.12483}
}
EUVIMED